Skip to main navigation Skip to search Skip to main content

A Phase 3, Randomized, 6-Month, Double Blind Trial in Subjects with Bipolar Disorder to Evaluate The Continued Safety and Maintenance of Effect of Zipasidone Plus a Mood Stablizer...

Project: Research

Project Details

StatusFinished
Effective start/end date05/9/06 → 05/8/08

Funding

  • Pfizer Incorporated: $32,233.66